Alerts

4283 total results. Page 126 of 172.

Karen Ellis Carr, Stanley H. Abramson, Katie Heilman
The United States Department of Agriculture and the Food and Drug Administration have recently initiated processes to evaluate and propose revisions to their approaches to the regulation of products of agricultural biotechnology.
On July 11, 2018, the House Energy and Commerce Subcommittee on Communications and Technology held a hearing titled “Protecting Customer Proprietary Network Information in the Internet Age.”
David R. Hamill, Nancy A. Noonan, John Gurley, Kay C. Georgi, Leah Scarpelli, Antonio J. Rivera
On July 6, 2018, the implementation day for the Section 301 “List 1” duties, the United States Trade Representative released the procedures for filing exclusion requests for List 1 products subject to the 25 percent tariff pursuant to Section 301 of the Trade Act of 1974.
Michael T. Kelly
The association between the alcohol beverage and cannabis industries continues to grow. Dan O'Neill, a former CEO of Molson Brewery and past senior executive at Campbell Soup Company and H.J. Heinz, has recently joined the board of CannaRoyalty.
On June 28, 2018, the Securities and Exchange Commission (SEC) voted to amend the definition of “smaller reporting company” to allow more companies to use the scaled disclosure requirements available to smaller reporting companies.
The Supreme Court of the United States recently tackled privacy in the mobile age and agreed that cell phone location is something that is protected.
Within hours of its unanimous passing in both the California State Senate and Assembly, Governor Jerry Brown signed the strongest online privacy law in the country, the California Consumer Privacy Act of 2018.
Timothy J. Feighery, Lee M. Caplan, Ucheora Onwuamaegbu*
The Monthly Wrap: News, insights, and analysis from Arent Fox's International Arbitration team.
Birgit Matthiesen
Today, the Government of Canada released the final list of goods that will be subject to retaliatory tariffs effective July 1, 2018.
Caroline Turner English, Alison Lima Andersen
The Fifth Circuit recently held that plaintiffs seeking benefits, under plans governed by the Employee Retirement Income Security Act of 1974 and non-ERISA plans, need not identify and include specific plan provisions in their complaints to survive motions to dismiss.
Douglas A. Grimm, Hillary M. Stemple, Kathryn L. Steffen
On June 20, 2018, the Centers for Medicare & Medicaid Services issued a Request for Information seeking input from the public on how to address the undue regulatory impact and burden imposed on health care providers under the Stark Law.
Douglas A. Grimm, Hillary M. Stemple
Geoffrey Starks testified on Wednesday, June 20, 2018 before the Senate Committee on Commerce, Science, and Transportation.
M. Scott Peeler, Andrew Dykens
The US Department of Justice remained busy in its first year of the Trump Administration, charging 20 individuals with violations under the US Foreign Corrupt Practices Act — the second highest year of individual prosecutions since 1977.
Michael L. Stevens
On June 19, 2018, voters in Washington, DC approved Initiative 77 by a vote of 55.14 percent to 44.86 percent.
Michael L. Stevens
In the wake of the “Me Too” movement and following a trend of recent legislation, on May 15, 2018, Maryland Governor Larry Hogan (R) approved the Disclosing Sexual Harassment in the Workplace Act of 2018. The Act becomes effective on October 1, 2018.
Julius A. Rousseau, III, James M. Westerlind
The US Court of Appeals for the Second Circuit just issued a 32-page decision affirming the district court’s conflict of laws ruling, in favor of an Arent Fox LLP client, that New York law, rather than New Jersey law, applied to an insurable interest dispute between AEI Life LLC and Lincoln Benefit
Where is my child? Ask any parent who has ever lost sight of their child and they will tell you that these short moments of panic can feel like a lifetime. Thankfully, events like these can in many ways soon be a thing of the past.
Karen Ellis Carr, Stanley H. Abramson, Emily M. Leongini
Late last week, the Food and Drug Administration declared its jurisdiction over animal cell culture technology through a public meeting announcement and a statement by Commissioner Scott Gottlieb.
M. Scott Peeler, Glenn C. Colton, Kay C. Georgi, Terree A. Bowers, Peter V. B. Unger
When companies create anti-bribery programs and provide training to staff, many understandably focus on bribery of foreign government officials.
Aphrodite Kokolis
In a decisive victory for class action defendants, the U.S. Supreme Court held that a pending class action tolls the statute of limitations only for putative class members’ individual claims, and not for any “follow-on” class actions they file on their own.
Douglas A. Grimm, Hillary M. Stemple
Edwin Simcox, Acting Chief Technology Officer for the US Department of Health and Human Services (HHS), lauded telehealth as an innovation that potentially offers ways to address HHS’s four key priorities.
David R. Hamill, David Llorente, Leah Scarpelli
On June 15, the United States Trade Representative released two product lists relating to Section 301 duties.
Douglas A. Grimm, Hillary M. Stemple
The Department of Health and Human Services OIG has issued an advisory opinion approving an arrangement involving the provision of free telemedicine equipment and services by a provider to a potential referral source.
Stephanie Trunk
The California Office of Statewide Health Planning and Development (OSHPD) has posted a preliminary working draft of the regulations implementing California’s prescription drug price transparency law.
Stephanie Trunk
Connecticut and Maine recently joined the increasing number of states to enact drug price transparency laws. Maine’s drug price transparency law (the Maine Law) became effective on May 1, 2018.